What caused the epidemic of Pneumocystis pneumonia in European premature infants in the mid-20th century?

Pediatrics

Volumn 115, Issue 6, 2005, Pages

  Goldman, Armond S ^a,d   Goldman, Lynn R ^b   Goldman, Daniel A ^c  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Expert Health Data Programming Inc   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Africa; Europe; Pneumocystis pneumonia; Premature infants; Retrovirus; T cells

Indexed keywords

DIOXIN; XENOBIOTIC AGENT; ZINC;

BLOOD TRANSFUSION; BREAST MILK; EPIDEMIC; FUNGAL VIRULENCE; GENETIC DISORDER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPATHOLOGY; INTERSTITIAL PNEUMONIA; MALNUTRITION; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RETROVIRUS; REVIEW; T CELL DEPLETION; T LYMPHOCYTE; TAXONOMY; ARTICLE; CAMEROON; CELLULAR IMMUNITY; CYTOLOGY; CYTOMEGALIC INCLUSION BODY DISEASE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; EQUIPMENT; ETHNOLOGY; EUROPE; FEMALE; GERMANY; HISTORY; IMMUNE DEFICIENCY; IMMUNOLOGY; INFANT; INSTRUMENTATION; INTERSTITIAL LUNG DISEASE; MALE; MICROBIOLOGY; MIGRATION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; RETROVIRUS INFECTION; TOGO; TRAVEL; VIROLOGY; VIRULENCE; WAR;

BLOOD TRANSFUSION; CAMEROON; CYTOMEGALOVIRUS INFECTIONS; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; EMIGRATION AND IMMIGRATION; EQUIPMENT CONTAMINATION; EUROPE; FEMALE; GERMANY; HISTORY, 20TH CENTURY; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MALNUTRITION; MILK, HUMAN; PNEUMONIA, PNEUMOCYSTIS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROVIRIDAE INFECTIONS; TOGO; TRAVEL; VIRULENCE; WAR; XENOBIOTICS; ZINC;

EID: 27744508368     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-2157     Document Type: Review

References (138)

1. Gajdusek DC. Pneumocystis carinii as the cause of human disease: historical perspective and magnitude of the problem: introductory remarks. Natl Cancer Inst Monogr. 1976;43:1-11
2. Koop MJ. Pneumocystis-pneumoniae. Een studie naar anleididing van een epidemie in het praematurenpaviljoen van de St. Elisabethkliniek te Heerlen [doctoral thesis]. Heerlen, Netherlands: Winants; 1964s
3. Goudsmit J. Viral Sex: The Nature of AIDS. New York, NY: Oxford University Press; 1997:28-35
4. Rössle R. Referat über entzündung. Verh Dtsch Ges Pathol. 1923;19:18-68
5. Feyrter F. Über die pathologische anatomie der lungenverä nderungen beim keuchhusten. Frankf Z Pathol. 1927;35:213-255
6. Ammich O. Über die nitchsyphilitische interstitielle pneumonie des ersten kindesalters. Virchows Arch Pathol Anat Physiol Klin Med. 1938;302:539-554
7. Benecke E. Eigenartige bronchiolenerkrankung im ersten lebensjahr. Verh Dtsch Ges Pathol. 1938;31:402-406
8. Feyrter F. Über eine eigenartige form interstitieller lungenentzündung beim säugling und kleinkind. Munch Med Wochenschr. 1939;86:835-836
9. Bommer W. Pneumocystis carinii: erreger opportunistscher infektionen seit 40 jahren. die plasmazelluläre interstitielle pneumonie: die "pest" der frühgeborenen und schwachen säuglinge. Med Klin. 1994;89:376-382
10. Frenkel JK. Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview. J Eukaryot Microbiol. 1999;46:89S-92S
11. Kovács Z, Veress I, Márkus V, Páldy L. Die häufigkeitsbeeinflussenden Faktoren bei der interstitiellen plasmazellulenpneumonie der frühgeborenen. Monatsschr Kinderheilkd. 1966;114:476-479
12. Hallman N, Ylppö A. Mental and physical disturbances in children recovered from infantile plasma cell pneumonia. Acta Paediatr Suppl. 1954;43:382-396
13. Deamer DC, Zollinger HU. Interstitial plasma cell pneumonia of premature and young infants. Pediatrics. 1953;12:11-22
14. van der Meer G, Brug SL. Infection par Pneumocystis chez l'homme et chez les animaux. Ann Soc Belge Med Trop. 1942;22:301-307
15. Vanek J. Atipicka (intersiciálni) pneumonie deta, vyvolaná Pneumocystis carinii. Cas Lek Cesk. 1951;90:1121-1124
16. Vanek J, Jirovec O. Parasitäre pneumoniae, plasmazellulä renpneumonie der frühgeborenen, verurscaht durch Pneumocystis carinii. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg. 1952;158:120-127
17. Friedrich-Breuninger G, Duker G, Pixis A, Sperling G, Stroder J, Zahs E. Experiences in interstitial pneumonia in the premature infant. Critical report of personal observations during a 10-year period. Folia Clin Int (Barc). 1968;18:213-224
18. Greer FR. Feeding the premature infant in the 20th century. J Nutr. 2001;131:426S-430S
19. Coons AH, Leduc EH, Connolly JM. Studies on antibody production. I. A method for the histochemical demonstration of specific antibody and its application to a study of the hyperimmune rabbit. J Exp Med. 1955;102:49-60
20. Edman JC, Kovacs JA, Masur H, Santi DV, Elwood HJ, Sogin ML. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the ascomycetes fungi. Nature. 1988;334:519-522
21. Stringer JR. The identity of Pneumocystis carinii: not a single protozoan but a diverse group of exotic fungi. Infect Agents Dis. 1993;2:109-117
22. Giuntoli D, Stringer SL, Stringer JR. Extraordinarily low number of ribosomal RNA genes in P. carinii. J Eukaryot Microbiol. 1994;41:88S
23. Stringer JR. Pneumocystis. Int J Med Microbiol. 2002;292:391-404
24. Kaneshiro ES. Is Pneumocystis a plant? J Eukaryot Microbiol. 2002;49:367-373
25. Ma L, Imamichi H, Sukura A, Kovacs JA. Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species. J Infect Dis. 2001;184:1358-1362
26. Demanche C, Berthelemy M, Petit T, et al. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests coevolution. J Clin Microbiol. 2001;39:2126-2133
27. Itatani CA. Ultrastructural morphology of intermediate forms and forms suggestive of conjugation in the life cycle of Pneumocystis carinii. J Parasitol. 1996;82:163-171
28. Vargas Sl, Hughes WT, Santolaya ME, et al. Search for a primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32:855-861
29. Peglow SL, Smulian AG, Linke MJ, et al. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis. 1990;161:296-306
30. Wakefield AE, Stewart TJ, Moxon ER, Marsh K, Hopkin JM. Pneumocystis carinii is prevalent in healthy Gambian children. Trans R Soc Trop Med Hyg. 1990;84:800-802
31. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. Pneumocystis carinii pneumonia in the United States. Epidemiologic, diagnostic, and clinical features. Ann Intern Med. 1974;80:83-93
32. Young LS, ed. Pneumocystis carinii Pneumonia: Pathogenesis, Diagnosis, Treatment. New York, NY: Dekker; 1984
33. Hughes WT. Pneumocystis carinii Pneumonitis. Boca Raton, FL: CRC Press; 1987
34. Buckley RH. Primary immunodeficiency diseases: dissectors of the immune system. Immunol Rev. 2002;185:206-219
35. Najera O, Gonzalez C, Toledo G, et al. CD45RA and CD45RO isoforms in infected malnourished and infected well-nourished children. Clin Exp Immunol. 2001;126:461-465
36. Savino W. The thymus gland is a target in malnutrition. Eur J Clin Nutr. 2002;56(suppl 3):S46-S49
37. Prasad AS, Meftah S, Abdallah J, et al. Serum thymulin in human zinc deficiency. J Clin Invest. 1988;82:1202-1210
38. Bodey B, Bodey Jr B, Siegel SE, Kaiser HE. The role of zinc in pre- and postnatal thymic immunohistogenesis. In Vivo. 1998;12:695-722
39. Prasad AS. Effects of zinc deficiency on Th1 and Th2 cytokine shifts. J Infect Dis. 2000;182(suppl 1):S62-S68
40. Wellinghausen N. Immunobiology of gestational zinc deficiency. Br J Nutr. 2001;85(suppl 1):S81-S86
41. Dardenne M. Zinc and immune function. Eur J Clin Nutr. 2002;56(suppl 3):S20-S23
42. Prasad AS. Clinical spectrum of human zinc deficiency. In: Prasad AS, ed. Biochemistry of Zinc. New York, NY: Plenum Press; 1993:219-258
43. Mildvan D, Mathur U, Enlow RW, et al. Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med. 1982;96:700-704
44. Follansbee SE, Busch DF, Wofsy CB, et al. An outbreak of Pneumocystis carinii pneumonia in homosexual men. Ann Intern Med. 1982;96:705-713
45. Barre-Sinoulissi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983;220:868-871
46. Popovic MM, Sarngadharan MG, Read E, Gallo RC. Detection, isolation, and continuous production of a cytopathic retrovirus (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984;224:497-500
47. Alizon M, Montagnier L. Lymphadenopathy/AIDS virus: genetic organization and relationship to animal lentiviruses. Anticancer Res. 1986;6:403-411
48. Yasunaga Ji, Sakai T, Nosaka K, et al. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood. 2001;97:3177-3183
49. Takatsuki K, Yamaguchi K, Matsuoka M. ATL and HTLV-I-related diseases. In: Takatsuki K, ed. Adult T-Cell Leukemia. New York, NY: Oxford University Press; 1994:1-27
50. Von Berlin-Heimendahl S, Goetz O. Zur epidemiologie, therapie, und prophylaxe der interstiellen säuglingspneumonie. Z Kinderheilkd. 1957;79:680-720
51. Dutz W. Pneumocystis carinii pneumonia. Pathol Annu. 1970:5:309-341
52. Burke BA, Good RA. Pneumocystis carinii infection. Medicine (Baltimore). 1973;52:23-51
53. Umeta M, West C E, Verhoef H, Haidar J, Hautvast JG. Factors associated with stunting in infants aged 5-11 months in the Dodota-Sire District, rural Ethiopia. J Nutr. 2003;133:1064-1069
54. Sandstrom B, Cederblad A, Lonnerdal B. Zinc absorption from human milk, cow's milk, and infant formulas. Am J Dis Child. 1983;137:726-729
55. Krebs NF, Reidinger CJ, Hartley S, Robertson AD, Hambidge KM. Zinc supplementation during lactation: effects on maternal status and milk zinc concentrations. Am J Clin Nutr. 1995;61:1030-1036
56. King LE, Osati-Ashtiani F, Fraker PJ. Depletion of cells of the B lineage in the bone marrow of zinc-deficient mice. Immunology. 1995;85:69-73
57. Goldman, AS. Evolution of the mammary gland defense system and ontogeny of the immune system. J Mammary Gland Biol Neoplasia. 2002;7:277-289
58. low T cells in newborn blood. Biol Neonate. 1996;69:128-132
59. McVay LD, Carding SR. Generation of human γδ T-cell repertoires. Crit Rev Immunol. 1999;19:431-460
60. Ribeiro-do-Couto LM, Boeije LC, Kroon JS, et al. High IL-13 production by human neonatal T cells: neonate immune system regulator? Eur J Immunol. 2001;31:3394-3402
61. Vekemans J, Ota MO, Wang EC, et al. T cell responses to vaccines in infants: defective IFN-gamma production after oral polio vaccination. Clin Exp Immunol. 2002;127:495-498
62. White GP, Watt PM, Holt BJ, Holt PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol. 2002;168:2820-2827
63. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004;4:553-564
64. Georgeson GD, Szony BJ, Streitman K, Kovacs A, Kovacs L, Laszlo A. Natural killer cell cytotoxicity is deficient in newborns with sepsis and recurrent infections. Eur J Pediatr. 2001;160:478-482
65. Schroeder HW Jr, Zhang L, Philips JB 3rd. Slow, programmed maturation of the immunoglobulin HCDR3 repertoire during the third trimester of fetal life. Blood. 2001;98:2745-2751
66. Linke MJ, Harris CE, Korfhagen TR, et al. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis. 2001;183:943-952
67. Rooney SA. Fatty acid biosynthesis in developing fetal lung. Am J Physiol. 1989;257:L195-L201
68. Hundeiker C, Pineau T, Cassar G, Betensky RA, Gleichmann E, Esser C. Thymocyte development in Ah-receptor-deficient mice is refractory to TCDD-inducible changes. Int J Immunopharmacol. 1999;21:841-859
69. ten Tusscher GW, Steerenberg PA, van Loveren H, et al. Persistent hematologic and immunologic disturbances in 8-year-old Dutch children associated with perinatal dioxin exposure. Environ Health Perspect. 2003;111:1519-1523
70. Weisglas-Kuperus NS, Patadin S, Berbers GA, et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect. 2000;108:1203-1207
71. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am. 1999;13:1091-1112
72. Dei-Cas E, Brun-Pascaud M, Bille-Hansen V, Allaert A, Aliouat EM. Animal models of pneumocystosis. FEMS Immunol Med Microbiol. 1998;22:163-168
73. Olsson M, Lidman C, Latouche S, et al. Identification of Pneumocystis carinii f. sp. Hominis gene sequences in filtered air in hospital environments. J Clin Microbiol. 1998;36:1737-1740
74. Manoloff ES, Francioli P, Taffé P, van Melle G, Bille J, Hauser PM. Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study. Emerg Infect Dis. 2003;9:132-134. Available at: www.cdc.gov/ncidod/EID/vol9no1/02-0141.htm. Accessed August 1, 2004
75. Hierholzer JC. Adenoviruses in the immunocompromised host. Clin Microbiol Rev. 1992;5:262-274
76. Taylor CE, Osman HK, Turner AJ, et al. Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency. Commun Dis Public Health. 1998;1:202-203
77. Crooks BN, Taylor CE, Turner AJ, et al. Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit. Bone Marrow Transplant. 2000;26:1097-1102
78. Toti P, De Felice C, Stumpo M, et al. Acute thymic involution in fetuses and neonates with chorioamnionitis. Hum Pathol. 2000;31:1121-1128
79. Chaga C. Nova tripanozomiazaea humana. Estudos sobre a morfolojia e o cielo evoluto do Schizotrypanum cruzi n. gen., n. sp., ajente etiologio de nova entidade morbida de homen. Mem Inst Oswaldo Cruz, Rio. 1909;1:159-218
80. Cotta-De-Almeida V, Bonomo A, Mendes-da-Cruz DA, et al. Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration. Eur J Immunol. 2003;33:2439-2448
81. Ouaissi A, Guevara-Espinoza A, Chabe F, Gomez-Corvera R, Taibi A. A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione. Immunol Lett. 1995;48:221-224
82. Alford CA, Britt WJ. Cytomegalovirus. In: Fields BN, Knipe DM, Chanock RM, et al, eds. Fields Virology. 2nd ed. New York, NY: Raven Press; 1990:1981-2010
83. Yasuda A, Kimura H, Hayakawa M, et al. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay. Pediatrics. 2003;111:1333-1336
84. Adler SP, Chandrika T, Lawrence L, Baggett J. Cytomegalovirus infections in neonates acquired by blood transfusions. Pediatr Infect Dis J. 1983;2:114-118
85. Beck K, Meyer-Konig U, Weidmann M, Nern C, Hufert FT. Human cytomegalovirus impairs dendritic cell function: a novel mechanism of human cytomegalovirus immune escape. Eur J Immunol. 2003;33:1528-1538
86. Hamperl H. Pneumocysytis infection and cytomegaly of the lungs in newborn and adult. Am J Pathol. 1956;32:1-13
87. Gambarotto K, Ranger-Rogez S, Aubard Y, et al. Primary cytomegalovirus infection and pregnant women: epidemiological study on 1100 women at Limoges [in French]. Pathol Biol. 1997;45:453-461
88. Boppana SB, Pass RF, Britt WJ, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J. 1992;11:93-99
89. Fawzi W, Msamanga G, Renjifo B, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS. 2001;15:1157-1165
90. Duong T, Ades AE, Gibb DM, Tookey PA, Masters J. Vertical transmission rates for HIV in the British Isles: estimates based on surveillance data. BMJ. 1999;319:1227-1229
91. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics. 1999;104(5). Available at: www.pediatrics.org/cgi/content/full/104/5/e56
92. Joshi VV, Oleske JM. Pathologic appraisal of the thymus gland in acquired immunodeficiency syndrome in children. A study of four cases and a review of the literature. Arch Pathol Lab Med. 1985;109:142-146
93. Grody WW, Fligiel S, Naeim F. Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol. 1985;84:85-95
94. Rosenzweig M, Clark DP, Gaulton GN. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS. 1993;7:1601-1605
95. Gitlin D, Craig JM. The thymus and other lymphoid tissues in congenital agammaglobulinemia. I. Thymic alymphoplasia and lymphocytic hypoplasia and their relation to infection. Pediatrics. 1963;32:517-530
96. Hitzig WH. Congenital thymic and lymphocytic deficiency disorders. In: Stiehm RA, Fulginiti VA, eds. Immunologic Disorders in Infants and Children. Philadelphia, PA: W.B. Saunders; 1973:215-235
97. Kober B, Muldoon M, Theiler J, et al. Timing the ancestor of the HIV-1 pandemic strains. Science. 2000;288:1789-1796
98. Crandall KA. Multiple interspecies transmissions of human and simian T-cell leukemia/lymphoma virus type I sequences. Mol Biol Evol. 1996;13:115-131
99. Van Dooren S, Salemi M, Vandamme AM. Dating the origin of the African human T-cell lymphotropic virus type-I (HTLV-I) subtypes. Mol Biol Evol. 2001;18:661-671
100. Gessain A, Mahieux R. Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus [in French]. Bull Soc Pathol Exot. 2000;93:163-171
101. History of Germany. In: New Encyclopaedia Britannica. Macropedia Volume 8. 25th ed. Chicago, IL: Encyclopaedia Britannia, Inc; 1974:69-126
102. Meertens L, Rigoulet J, Mauclere P, et al. Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology. 2001;287:275-285
103. Meertens L, Mahieux R, Mauclere P, Lewis J, Gessain A. Complete sequence of a novel highly divergent simian T-cell lymphotropic virus from wild-caught red-capped mangabeys (Cercocebus torquatus) from Cameroon: a new primate T-lymphotropic virus type 3 subtype. J Virol. 2002;76:259-268
104. Peeters M, Courgnaud V, Abela B, et al. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis. 2002;8:451-457
105. Peeters M, Fransen K, Delaporte E, et al. Isolation and characterization of a new chimpanzee lentivirus (simian immunodeficiency virus isolate cpz-ant) from a wild-captured chimpanzee. AIDS. 1992;6:447-451
106. Lumey LH, Van Poppel FW. The Dutch famine of 1944-45: mortality and morbidity in past and present generations. Soc Hist Med. 1994;7:229-246
107. Lylloff K. Causes of death of German refugee children in 1945 [in Danish]. Ugeskr Laeger. 2000;162:1227-1230
108. Fujino T, Nagata Y. HTLV-I transmission from mother to child. J Reprod Immunol. 2000;47:197-206
109. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359:1178-1186
110. Coutsoudis A, Dabis F, Fawzi W, et al. Breastfeeding and HIV International Transmission Study Group. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166
111. Mollison PL, Egelfriet P. Blood transfusion. Semin Hematol 1999;36:4(suppl 7):48-58
112. Schneinder WH. Blood transfusion between the wars. J Hist Med Allied Sci. 2003;58:187-224
113. Hess JH. Premature infants. In: Abt IA, ed. Pediatrics. Vol II. Philadelphia, PA: W.B. Saunders; 1921:512
114. Levenson SM, Hopkins BS, Waldron M, Canham JE, Seifter E. Early history of parenteral nutrition. Fed Proc. 1984;43:1391-1406
115. Lohr H. Pulmonale komplikationen transfusions-belundlung von frugeburten. Ein beitrag zur pathogenese der interstitiellen pneumonie. Monatsschr Kinderheilkd. 1942;91:362-368
116. Prichard E. The Infant. A Handbook of Modern Treatment. London, United Kingdom: Edward Arnold & Co; 1938:139, 156-157
117. Becton-Dickinson Corp. Hypodermic syringe points the way to Becton Dickinson's progress. Echo. 1991;11(3):1-3
118. Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358:1989-1992
119. Dunham EC. Premature Infants: A Manual for Physicians. Children's Bureau Publication 325. Washington, DC: Federal Security Agency; 1948
120. Hey E. Vitamin K - what, why, and when. Arch Dis Child Fetal Neonatal Ed. 2003;88:F80-F83
121. Wasik TJ, Jagodzinski PP, Hyjek EM, et al. Diminished HIV-specific CTL activity is associated with lower type 1 and enhanced type 2 responses to HIV-specific peptides during perinatal HIV infection. J Immunol. 1997;158:6029-6036
122. Wasik TJ, Bratosiewicz J, Wierzbicki A, et al. Protective role of β-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol. 1999;162:4355-4364
123. Manel N, Kinet S, Battini JL, Kim FJ, Taylor N, Sitbon M. The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis. Blood. 2003;101:1913-1918
124. Goldman AS, Prabhakar BS. Immunology. In: Baron SB, ed. Medical Microbiology. 4th ed. Galveston, TX: University of Texas Medical Branch Press; 1996:1-34
125. Robinson J, Marsh SG. The IMGT/HLA sequence database. Rev Immunogenet. 2000;2:518-531
126. Farquhar C, Rowland-Jones S, Mbori-Ngacha D, et al. Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV type 1 transmission. AIDS Res Hum Retroviruses. 2004;20:692-697
127. Altfeld M, Addo MM, Rosenberg ES, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS. 2003;17:2581-2591
128. den Uyl D, van der Horst-Bruinsma IE, van Agtmael M. Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Rev. 2004;6:89-96
129. Rizzo G, Caroli G. The plague from antiquity to today and its final incursions into southern Italy [in Italian]. Ann Ig. 2002;14(1 suppl 1):141-152
130. Rollins SE, Rollins SM, Ryan ET. Yersinia pestis and the plague. Am J Clin Pathol. 2003;119(suppl):S78-S85
131. Duncan SR, Scott S, Duncan CJ. Modeling the dynamics of scarlet fever epidemics in the 19th century. Eur J Epidemiol. 2000;16:619-626
132. Oxford JS, Sefton A, Jackson R, Innes W, Daniels RS, Johnson NP. World War I may have allowed the emergence of "Spanish" influenza. Lancet Infect Dis. 2002;2:111-114
133. Zierdt CH, Robertson EA, Williams RL, MacLowry JD. Computer analysis of Staphylococcus aureus phage typing data from 1957 to 1975, citing epidemiological trends and natural evolution within the phage typing system. Appl Environ Microbiol. 1980;39:623-629
134. Galvani AP, Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci USA. 2003;100:15276-15279
135. Grenfell BT, Pybus OG, Gog JR, et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science. 2004;303:327-332
136. Seifarth W, Krause U, Hohenadl C, Baust C, Hehlmann R, Leib-Mosch C. Rapid identification of all known retroviral reverse transcriptase sequences with a novel versatile detection assay. AIDS Res Hum Retroviruses. 2000;16:721-729
137. Lange M, Klein EB. Epidemic of Pneumocystis pneumonia in children before the AIDS era [letter]. Lancet. 1991;338:1340-1341
138. Goudsmit J. Viral Fitness: The Next SARS and West Nile in the Making. New York, NY: Oxford University Press; 2004:108-125